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Alzheimer’s disease (AD) results in cognitive decline
and altered network activity, but the mechanisms
are unknown. We studied human amyloid precursor
protein (hAPP) transgenic mice, which simulate key
aspects of AD. Electroencephalographic recordings
in hAPP mice revealed spontaneous epileptiform
discharges, indicating network hypersynchrony, pri-
marily during reduced gamma oscillatory activity.
Because this oscillatory rhythm is generated by in-
hibitory parvalbumin (PV) cells, network dysfunction
in hAPP mice might arise from impaired PV cells.
Supporting this hypothesis, hAPP mice and AD
patients had decreased levels of the interneuron-
specific and PV cell-predominant voltage-gated
sodium channel subunit Nav1.1. Restoring Nav1.1
levels in hAPP mice by Nav1.1-BAC expression
increased inhibitory synaptic activity and gamma
oscillations and reduced hypersynchrony, memory
deficits, and premature mortality. We conclude that
reduced Nav1.1 levels and PV cell dysfunction
critically contribute to abnormalities in oscillatory
rhythms, network synchrony, and memory in hAPP
mice and possibly in AD.INTRODUCTION
Alzheimer’s disease (AD) is incurable and increasing in preva-
lence in aging populations. Diverse lines of evidence suggest
that amyloid-b (Ab) peptides contribute to AD pathogenesis
(Huang and Mucke, 2012). Although pathological levels of Ab
enhance synaptic depression and impair synaptic plasticity at
glutamatergic synapses (Hsieh et al., 2006; Kamenetz et al.,708 Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc.2003; Walsh et al., 2002), its effects on circuits and neuronal
network activity are poorly understood (Palop and Mucke,
2010). Human amyloid precursor protein (hAPP) transgenic lines
with high Ab levels exhibit altered network activity, reflected in
abnormal expression of activity-regulated genes, clusters of
hyperactive and hypoactive neurons, network hyperexcitability,
and spontaneous epileptiform activity (Busche et al., 2008;
Harris et al., 2010; Minkeviciene et al., 2009; Palop et al., 2007;
Roberson et al., 2011). In AD patients and nondemented
humans, amyloid deposits are predominately distributed along
networks with aberrant neuronal activity (Buckner et al., 2005;
Sperling et al., 2009), suggesting activity-driven pathology
(Bero et al., 2011). Thus, network abnormalities leading to or
induced by Ab accumulationmay be a relatively early pathogenic
event in AD (Sperling et al., 2009). The incidence of epileptic
activity is also increased in sporadic AD (Amatniek et al., 2006)
but is particularly high in pedigrees with early-onset autosomal-
dominant AD (Cabrejo et al., 2006; Larner and Doran, 2006;
Palop and Mucke, 2009; Snider et al., 2005). Therefore, deter-
mining the mechanisms of AD-related network dysfunction and
its relation to cognitive decline is an important objective.
hAPP mice are experimental models of cerebral Ab amyloid-
osis and of synaptic and cognitive dysfunctions. hAPPJ20
mice simulate several key aspects of sporadic and autosomal
dominant AD, including deficits in learning and memory, behav-
ioral abnormalities, synaptic alterations, amyloid plaques, and
gliosis (Cheng et al., 2007; Cisse´ et al., 2011; Palop et al.,
2007; Palop et al., 2003; Roberson et al., 2007). Previously, we
discovered spontaneous epileptic activity, indicating network
hypersynchrony, in cortical and hippocampal electroencephalo-
graphic (EEG) recordings of hAPPJ20 mice (Palop et al., 2007).
Here, we determined whether these large-scale events of
network hypersynchronization are linked to specific abnormali-
ties in oscillatory rhythmic activity (‘‘brain waves’’). Interestingly,
network hypersynchrony emerged during reduced gamma
activity, a high-frequency oscillatory rhythm that depends on the
synaptic activity of parvalbumin-positive inhibitory interneurons
(PV cells) and contributes to cognitive functions (Cardin et al.,
2009; Korotkova et al., 2010; Mann and Paulsen, 2007; Sohal
et al., 2009). We therefore tested the hypothesis that abnormal-
ities in network synchrony, oscillatory rhythms, and cognitive
functions in hAPP mice arise from impaired PV cells.
Voltage-gated sodium channels (VGSC) control cellular and
network excitability by modulating synaptic activity in specific
neuronal subtypes (Meisler and Kearney, 2005). Sporadic loss-
of-function mutations or haploinsufficiency of the VGSC subunit
Nav1.1 due to genomic microdeletions cause epilepsy syn-
dromes (Catterall et al., 2010; Suls et al., 2006). Because
Nav1.1 is expressed predominantly in PV cells (Ogiwara et al.,
2007; Wang et al., 2011), network hypersynchrony in these
epilepsies may arise from impaired PV cells (Ogiwara et al.,
2007; Yu et al., 2006). Dysfunction of PV cells has also been
implicated in cognitive alterations and psychiatric symptoms in
other disorders associated with altered network activity, in-
cluding schizophrenia and autism (Fazzari et al., 2010; Sohal
et al., 2009).
Consistent with a critical role for altered Nav1.1 levels and PV
cell-dependent activity in the pathogenesis of network and
cognitive dysfunction of hAPPmice, reversingNav1.1 reductions
in hAPPJ20 mice by Nav1.1-BAC transgene expression restored
PV cell-dependent gamma oscillations and inhibitory synaptic
currents and reduced premature mortality, network hyper-
synchrony, and memory deficits in these mice. Thus, Nav1.1
depletion in PV cells may contribute to network dysfunction
and cognitive deficits in hAPP mice and possibly in AD. Im-
proving the function of PV cells and gamma activity may be of
therapeutic benefit in AD and other brain disorders associated
with altered network activity and cognitive impairments.
RESULTS
Network Hypersynchrony Emerges during Reduced
Gamma Activity in hAPPJ20 Mice
The combined activity of neural networks generates specific
oscillatory patterns that can be measured by EEG recordings.
We first determine whether any patterns of abnormal EEG
activity are associated with spontaneous epileptiform dis-
charges (spikes) in hAPPJ20 mice. Oscillations of 0–100 Hz
and spikes were monitored in 1 min intervals for 60 min over
the parietal cortex of nontransgenic (NTG) and hAPPJ20 mice.
hAPPJ20 mice had prominent abnormalities in the intensity of
gamma oscillations (20–80 Hz; Figure 1A), including abrupt fluc-
tuations and depressed intensity of gamma activity (Figures 1A
and 1B). Consistent with previous findings (Harris et al., 2010;
Minkeviciene et al., 2009; Palop et al., 2007; Roberson et al.,
2011), hAPPJ20 mice had frequent spikes (Figures 1A and 1C).
Spikes occurred in clusters and were closely related to the inten-
sity of gamma oscillations (Figures 1A and 1D). Linear regression
analyses within individual and among hAPPJ20mice revealed an
inverse relationship between the intensity of gamma activity and
the spike rate (Figure 1E). Across hAPPJ20 mice, spikes were
absent during periods of high-intensity gamma activity, common
during intermediate-intensity gamma activity, and frequent dur-
ing low-intensity gamma activity (Figure 1F). Thus, network
hypersynchrony emerges during reduced gamma activity.Equivalent results were found when periods of high- and
low-intensity gamma activity were compared in each hAPPJ20
mouse (Figures S1A and S1B available online). Because gamma
oscillations are generated by the synaptic activity of PV cells
(Cardin et al., 2009; Sohal et al., 2009), we hypothesized that
the above network alterations arise from PV cell impairments
and that enhancing gamma activity or PV cell function would
be of benefit in hAPPJ20 mice.
In support of the latter possibility, exploratory behavior
was associated with increased gamma activity and fewer spikes
in hAPPJ20 mice (Figure S1C). Interestingly, only hAPPJ20
mice with increased gamma activity during exploration had re-
ductions in spikes (Figure 1G). Thus, gamma activity, but not
exploratory behavior per se, modulates epileptiform discharges
in these mice.
Inhibitory Synaptic Impairments and PV Cell
Dysfunction in hAPPJ20 Mice
In agreement with previous findings (Roberson et al., 2011),
hAPPJ20 mice had reduced glutamatergic transmission in the
parietal cortex (Figure 2A). To explore whether GABAergic func-
tion is altered in hAPPJ20 mice, we recorded miniature and
spontaneous inhibitory postsynaptic currents (mIPSC versus
sIPSC, respectively) from layer II/III pyramidal neurons. When
action potential-driven neuronal activity was blocked, hAPPJ20
and NTG mice had similar amplitudes and frequencies of
mIPSCs (Figures 2B and 2C), suggesting a normal number of
functional GABAergic synapses. However, when action poten-
tial-driven neuronal activity was present, hAPPJ20 mice had
significant reductions in sIPSC frequency (Figures 2B and 2C),
indicating activity-dependent impairment in GABAergic func-
tion. Thus, interneuronal excitability is likely compromised by
intrinsic or circuit alterations in hAPPJ20 mice (Roberson
et al., 2011).
To determine whether intrinsic properties of fast-spiking PV
cells are altered in hAPPJ20 mice, we crossed hAPPJ20 mice
with bacterial artificial chromosome (BAC) transgenic mice
expressing enhanced GFP (eGFP) directed by GAD67 regulatory
sequences (GAD67eGFP) (line G42, Chattopadhyaya et al., 2004)
to produce GAD67eGFP mice without or with hAPP expression
(NTG/GAD67eGFP and hAPPJ20/GAD67eGFP, respectively).
eGFP-labeled fast-spiking GABAergic interneurons and nonla-
beled pyramidal cells were assessed by patch-clamp record-
ings. Fast-spiking interneurons, but not pyramidal cells, had
more depolarized resting membrane potentials in hAPPJ20/
GAD67eGFP mice than in NTG/GAD67eGFP mice (Figure 2D and
Table S1). Action potential properties were examined using
current steps of increasing amplitude (800 ms, 20 pA steps).
Although the pattern and frequency of action potentials
across different stimulus intensities (0–320 pA above threshold)
did not differ between genotypes (Figure 2E and Figures
S2A–S2C), fast-spiking interneurons had smaller action
potential amplitudes in hAPPJ20/GAD67eGFP mice than in
NTG/GAD67eGFP mice both at resting membrane potentials
and when resting membrane potentials were held constant at
70 mV (Figures 2F and 2G and Table S1). No differences in
action potential amplitudes were found in layer II/III pyramidal
cells (Figure 2G).Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc. 709
AB C
D E
F G
Figure 1. Network Hypersynchrony Emerges during Reduced Intensity of Gamma Activity in hAPPJ20 Mice
EEG recordings from the left (L) and right (R) parietal cortex (PC) in NTG (n = 8) and hAPPJ20 (n = 11) mice. The intensity of gamma activity (20–80 Hz), frequency
of epileptiform discharges (spikes), and exploratory activity were measured in 1 min intervals for 60 min. Numbers in bars are minutes of EEG recording (C and F)
or mice (G).
(A) EEG recordings (top), spike distribution (middle), and full frequency range (0–100 Hz) spectrogram (bottom) from an hAPPJ20 mouse. Spike rate increases
during periods of reduced gamma intensity.
(B) Longitudinal quantifications of gamma activity in hAPPJ20 (black) and NTG (green) mice illustrating abnormal patterns of gamma activity in hAPPJ20 mice.
Each trace represents a mouse.
(C) hAPPJ20 mice, but not NTG controls, displayed frequent spikes (arrowheads).
(D) Longitudinal quantification of gamma activity (top trace) and spike rate (bottom histogram).
(E) Linear regression analyses revealed an inverse relationship between intensity of gamma activity and spike rate in individual (left) and among (right)
hAPPJ20 mice.
(F) Minutes with low, intermediate (inter), or high intensity of gamma activity (left) had high, intermediate, or low spike rates (right), respectively.
(G) Only hAPPJ20 mice with increased gamma activity during exploration (responders, RP) (left) had reductions in spikes (right).
*p < 0.05, **p < 0.01, ***p < 0.001 by unpaired (C) or paired (G) two-sample t test or ANOVA and Tukey test (F). Bars represent mean ± SEM. See Figure S1 for
supporting data.Reduced VGSC Levels in PV Cells of hAPPJ20 Mice
and in AD Brains
Because action potential-driven synaptic activity depends on
VGSCs (Catterall et al., 2010; Meisler and Kearney, 2005)710 Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc.(Figures S2D–F), we measured the levels of the four main VGSC
subunits expressed in the central nervous system (Nav1.1,
Nav1.2, Nav1.3, and Nav1.6) (Meisler and Kearney, 2005).
hAPPJ20 mice had reduced levels of Nav1.1 and Nav1.6, but
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Figure 2. Inhibitory Synaptic Impairments and PV Cell Dysfunction in hAPPJ20 Mice
(A–C) Synaptic alterations in layer II/III pyramidal neurons (Pyr) of the parietal cortex in hAPPJ20 (hAPPJ20/Pyr; red) and NTG (NTG/Pyr; black) mice.
(A and B) Frequency of miniature (mini, m) and spontaneous (spont, s) excitatory (A) and inhibitory (B) postsynaptic currents (mIPSC, sIPSC,mEPSC, and sEPSC).
#p < 0.05, ##p < 0.001 (Tukey test).
(C) Recordings of mIPSCs (top) and sIPSCs (bottom).
(D–G) Synaptic alterations in fast-spiking GABAergic cells of the parietal cortex in GAD67eGFP transgenic mice without (NTG/GAD67eGFP; black) or with hAPP
(hAPPJ20/GAD67eGFP; red) expression.
(D) Resting membrane potential (RMP) of pyramidal cells and fast-spiking GABAergic cells. ***p < 0.001 (t test).
(E) Spike traces from fast-spiking GABAergic cells (red) evoked by 800 ms current of 380 pA.
(F)Mean action potential amplitudes for the first spike at threshold and for the last spike of the train at each 20 pA current step above threshold. Neuronswere held
at 70 mV between current steps (n = 10–14 cells per genotype). **p < 0.01 (t test), ***p < 0.001 (two-way ANOVA).
(G) Reduced action potential amplitudes for the first spike at threshold in fast-spiking GABAergic cells of hAPPJ20/GAD67eGFP mice. Neurons were at RMP (left)
or held at 70 mV (right) between current steps. *p < 0.05, **p < 0.01 (t test).
Numbers in bars are cells (A, B, D, G). Values are mean ± SEM. See Figure S2 and Table S1 for supporting data.not Nav1.2 and Nav1.3, in the parietal cortex (Figure 3A). We also
analyzedNav1.1, Nav1.2, andNav1.6 levels in the inferior parietal
cortex of patients with AD and nondemented controls. In the
AD cases, Nav1.1 levels were significantly depleted, Nav1.6
levels showed a trend toward depletion, and Nav1.2 levels
were unchanged (Figure 3B).
VGSCs show distinct patterns of expression across neuronal
populations (Lorincz and Nusser, 2008; Meisler and Kearney,
2005; Ogiwara et al., 2007), and the effects of reduced VGSC
expression on network activity depend on the type of neuron
affected. In agreement with previous reports (Lorincz and
Nusser, 2008; Meisler and Kearney, 2005; Ogiwara et al.,
2007), Nav1.1 mRNA was highly expressed by a subset of
neurons in the hippocampus and parietal cortex (Figure 3C
and Figure S3A). Double labeling for Nav1.1 mRNA and PV
showed near complete colocation of these gene products
(Figures 3C and S3A). Nav1.6 mRNA was highly expressed by
the majority of hippocampal neurons and a subset in the parietal
cortex (Figure S3B). Double labeling for Nav1.6 mRNA and PV
revealed near complete colocation in the parietal cortex (Fig-
ure S3B). Consistent with these results and the expression ofeGFP in PV cells in line G42 (Chattopadhyaya et al., 2004),
Nav1.1 and Nav1.6 were expressed by green fluorescent cells
in the parietal cortex of GAD67eGFP mice (Figures 3D and 3E).
Thus, Nav1.1 and Nav1.6 expression in the parietal cortex is
restricted primarily to PV cells. Similar results were found in
primary cell cultures (Figure S3C).
Similar expression patterns were found in hAPPJ20 mice
(Figure 3F). However, quantification of PV- and Nav1.1-positive
cells and Nav1.1 mRNA signals in PV cells showed reduced
numbers of Nav1.1-positive PV cells and reduced Nav1.1mRNA
expression in PV cells in the parietal cortex of hAPPJ20 mice
(Figure 3G), indicating reduced Nav1.1 levels in PV cells in
hAPPJ20 mice.
Inhibiting VGSCs Reduces Gamma Activity and
Enhances Network Hypersynchronization and Learning/
Memory Impairments in hAPPJ20 Mice
To explore potential relations among VGSCs, gamma oscilla-
tions, and network hypersynchronization in hAPP mice, we
inhibited VGSC function with riluzole or phenytoin (Spadoni
et al., 2002) and monitored neural network activity by EEG.Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc. 711
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Figure 3. Reduced Nav1.1 Levels in PV Cells of hAPPJ20 Mice and in AD Brains
(A–B) Parietal cortex from mice and inferior parietal cortex from humans was dissected and VGSC levels were determined by western blot analyses.
(A) Representative western blots and quantification of Nav1.1, Nav1.2, Nav1.3, and Nav1.6 in hAPPJ20 and NTG mice.
(B) Representative western blots and quantification of Nav1.1, Nav1.2, and Nav1.6 levels in nondemented controls and AD cases.
(C–G) Double fluorescence in situ hybridization for Nav1.1 (red) and immunohistochemistry for PV (green) on cryosections from NTG, hAPPJ20, and
GAD67eGFP mice.
(C) In NTG mice, Nav1.1 mRNA was expressed at high levels by PV cells. Arrowheads in bottom panels (merged) indicate single- (PV, green; Nav1.1, red) or
double-labeled (yellow) cells.
(D and E) In GAD67eGFP mice, Nav1.1 (D) and Nav1.6 (E) mRNAs were highly expressed by GAD67eGFP-positive (green) cells.
(F) In hAPPJ20 mice, Nav1.1 mRNA expression was reduced in the parietal cortex (compare with C).
(G) hAPPJ20 mice had no reductions of PV cells in the parietal cortex (left) but had fewer Nav1.1-positive PV cells (middle) and lower Nav1.1mRNA expression in
PV cells (right) than controls.
*p < 0.05, **p < 0.01, ***p < 0.001 (t test). Scale bars: 50 mm (C and F); 5 mm (D and E). Values are mean ± SEM. Numbers in bars are mice (A), human cases (B), or
cells (G). See Figure S3 for supporting data.Riluzole reduced the intensity of gamma oscillations within
minutes and triggered intense epileptiform activity in hAPPJ20
mice, but not in NTG controls (Figures 4A–4C). These effects
were independent of exploratory activity (Figure S4A). Phenytoin
had similar effects (Figures S4B and S4C). These results strongly
suggest that VGSC hypofunction is causally linked to abnormal
gamma activity and network hypersynchrony in hAPPJ20 mice.
In agreement with our results, VGSC blockers also exacerbate
seizure activity in human epilepsies due to Nav1.1 loss-of-
function mutations (Liao et al., 2010; Striano et al., 2008).
Aberrant network activity may contribute to cognitive deficits
in hAPP mice (Ittner et al., 2010; Palop et al., 2007; Roberson
et al., 2011). Consistent with this notion and the above data, in-
hibiting VGSC function in hAPPJ20 mice also increased context-
dependent memory deficits (Figures 4D–4F). We measured712 Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc.context-dependent habituation (‘‘learning’’) and dishabituation
(‘‘forgetting’’) to a novel environment. Inhibiting VGSCs with
phenytoin markedly impaired context-dependent habituation to
a novel environment in hAPPJ20 mice, but not in NTG controls
(Figure 4D). Phenytoin also caused profound dishabituation in
hAPPJ20 mice, but not in NTG controls (Figure 4E). Thus, in-
hibition of VGSCs in hAPPJ20 mice, but not in NTG mice,
disrupts context-dependent learning and memory.
To ensure that these behavioral effects in hAPPJ20 mice
were not due to motor dysfunction, we increased trial frequency
to enhance learning. Under these conditions, we observed no
abnormalities in habituation and dishabituation in phenytoin-
and vehicle-treated hAPPJ20 mice (Figure 4F), suggesting that
their increased exploratory behavior in our original paradigm
was related to cognitive impairment rather than abnormal
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Figure 4. Inhibition of VGSCs Reduces
Gamma Activity and Enhances Hypersyn-
chrony and Context-Dependent Memory
Deficits in hAPPJ20 Mice
(A–C) EEG recordings from the left (L) and right (R)
parietal cortex (PC) were performed in hAPPJ20
(n = 11) and NTG (n = 5) mice before and after
intraperitoneal injection of the VGSC blocker
riluzole (RZL, 20 mg/kg).
(A) In hAPPJ20 mice, but not in NTG controls,
riluzole induced intense epileptiform activity
(spikes) within 10–15 min (arrowheads). Bottom
panels show the full frequency range spectro-
grams of the corresponding EEG recordings.
(B) 1 min (left) and 60 min (right) interval quan-
tifications of spikes 60 min before and after
riluzole injection. Two-way repeated-measures
ANOVA revealed significant effects of treat-
ment (p < 0.001), genotype (p < 0.01), and
treatment x genotype interaction (p < 0.001) (left).
(C) Intensity of gamma activity after riluzole
treatment normalized to gamma intensity during
the first minute of recording (100%). Riluzole
reduced gamma activity more prominently in
hAPPJ20 mice than in NTG controls. Treatment
(p < 0.001) and treatment x genotype interaction
(p < 0.001) effects by two-way repeated-
measures ANOVA.
(D–F) hAPPJ20 (n = 15–16 per group) and NTG
(n = 12–15 per group) mice were treated with
the VGSC blocker phenytoin (PHT) or vehicle
(Veh) and tested to assess context-dependent
habituation and dishabituation to a novel envi-
ronment.
(D) Phenytoin (85 mg/kg/day for 10 days) pre-
vented habituation only in hAPPJ20 mice. *p <
0.05 versus vehicle-treated hAPPJ20 mice (two-
way repeated-measures ANOVA and Bonferroni
test).
(E) Phenytoin also increased dishabituation
in hAPPJ20 mice. ***p < 0.001 versus vehicle-
treated hAPPJ20 mice (two-way repeated-
measures ANOVA and Bonferroni test).
(F) Phenytoin-treated hAPPJ20 mice fully
habituated to the environment when they were
exposed to it more frequently. However, after 10 days, phenytoin-treated hAPPJ20 mice showed increased dishabituation.
*p < 0.05, **p < 0.01 (unpaired t test), ##p < 0.01 (paired t test) (B). *p < 0.05, ***p < 0.001 versus vehicle-treated hAPPJ20 mice (ANOVA and Bonferroni test) (D–F).
Bar or line graphs represent mean ± SEM. See Figure S4 for supporting data.motor function. Retesting of fully habituated phenytoin-treated
hAPPJ20mice 10 days later again revealed prominent dishabitu-
ation (Figure 4F), suggesting enhanced forgetting. These results
are consistent with other data indicating that aberrant network
activity contributes to cognitive deficits in hAPP mice (Palop
et al., 2007; Roberson et al., 2011; Roberson et al., 2007).
Increasing Nav1.1 Levels in hAPPJ20 Mice
by Nav1.1-BAC Transgene Overexpression
To test whether reduced Nav1.1 levels cause abnormalities
in oscillatory rhythms, network synchronization, and cognitive
functions in hAPPJ20 mice, we increased Nav1.1 levels by
crossing them with Nav1.1-BAC transgenic mice (Figure 5A)
(Tang et al., 2009). Resulting F1 littermates were analyzed, which
included NTG, singly transgenic hAPPJ20 and Nav1.1, anddoubly transgenic hAPPJ20/Nav1.1 (bigenic) mice. As in NTG
mice (Figures 3C and S3A), Nav1.1mRNA was highly expressed
by a subset of neurons in Nav1.1-BAC transgenic mice (Fig-
ure 5B). Nav1.1-BAC transgenic mice, including Nav1.1 and
hAPPJ20/Nav1.1 mice, had Nav1.1 expression patterns like
those of NTG and hAPPJ20 mice but higher levels of expression
(Figures 5C and 5D). Similar to NTG and hAPPJ20 mice (Figures
3C and 3F), Nav1.1 and hAPPJ20/Nav1.1 mice had high levels of
Nav1.1 mRNA expression in PV cells, but not in other types of
interneurons or pyramidal cells, as shown by double labeling
for Nav1.1 mRNA and immunohistochemistry for PV, calretinin,
calbindin, and somatostatin (Figure 5E) (Ogiwara et al., 2007;
Wang et al., 2011). Nav1.1-BAC expression also increased
Nav1.1 protein levels in Nav1.1 and hAPPJ20/Nav1.1 mice (Fig-
ure 5F). Nav1.1 levels were much lower in hAPPJ20 mice thanCell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc. 713
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D
B Figure 5. Increasing Levels of Nav1.1 in hAPPJ20
Mice by Nav1.1-BAC Transgene Overexpression
(A) Nav1.1(SCN1A)-BAC transgene construct and PCR
detection of genotypes.
(B–E) Single bright-field in situ hybridization for Nav1.1
(B and C) and double fluorescence in situ hybridization
for Nav1.1 (red) and immunohistochemistry (green) (E)
for parvalbumin (PV), calretinin (CR), calbindin (CB), or
somatostatin (SOM) on cryosections from NTG, hAPPJ20,
Nav1.1, and hAPPJ20/Nav1.1 (bigenic) mice.
(B) As in NTGmice (Figure S3A),Nav1.1mRNA expression
in Nav1.1 mice was restricted to a few cells.
(C) Nav1.1 mRNA expression patterns were similar in all
genotypes.
(D) Densitometric analysis of Nav1.1 mRNA signals in the
parietal cortex (C) revealed that Nav1.1-BAC transgene
expression increased Nav1.1 mRNA levels in mice with
(p = 0.018) or without (p = 0.028) hAPP expression (two-
way ANOVA).
(E) In Nav1.1 and bigenic mice, Nav1.1 mRNA was
highly expressed by PV cells, but not by other interneu-
ronal populations. Arrowheads indicate single- (white) or
double-labeled (yellow) cells. Asterisks indicate very low
or putative expression.
(F) Representative western blots (left) and quantification
(right) of Nav1.1 levels in the parietal cortex. Nav1.1 levels
were increased by Nav1.1-BAC transgene expression in
mice with (p < 0.001) or without (p < 0.001) hAPP (two-way
ANOVA). **p < 0.01, ***p < 0.001 (one-way ANOVA and
Tukey test).
(G) Cortical Ab1-x levels in 3-month-old hAPPJ20 and
bigenic mice determined by ELISA.
Scale bars: 10 mm (B and E); 50 mm (C). Numbers in bars
are mice (D, F, G). Bars represent mean ± SEM.NTG mice but were nearly normal in hAPPJ20/Nav1.1 mice
(Figure 5F). Increasing Nav1.1 levels in hAPPJ20 mice did not
alter total Ab levels at 3 months of age (Figure 5G).714 Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc.Increasing Nav1.1 Levels Increases
Inhibitory Synaptic Currents and Gamma
Activity and Decreases Epileptiform
Activity
Consistent with the prominent expression of
Nav1.1 and Nav1.1-BAC in PV cells and the in-
volvement of these cells in inhibition of cortical
pyramidal cells and generation of gamma oscil-
lations (Cardin et al., 2009; Ogiwara et al., 2007;
Sohal et al., 2009), increasing Nav1.1 expres-
sion prevented abnormalities in spontaneous
IPSCs and gamma activity in hAPPJ20 mice
(Figure 6). In agreement with results shown in
Figure 2B, hAPPJ20mice had reduced frequen-
cies, but not amplitudes, of sIPSCs in layer II/III
and V pyramidal neurons of the parietal cortex
(Figures 6A–6C). Nav1.1-BAC expression pre-
vented this deficit in hAPPJ20/Nav1.1 mice
(Figures 6A and 6B), indicating that their re-
duced sIPSC frequency depends on Nav1.1
depletion.
Higher Nav1.1 expression also increased the
intensity of gamma activity in mice with or
without hAPP (Figure 6D). Cumulative frequency analysis of the
gamma intensity during all minutes recorded showed a signifi-
cant shift to higher intensity values in hAPPJ20/Nav1.1 mice
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Figure 6. Enhancing Nav1.1 Levels Increases Inhibitory Synaptic Currents and Gamma Activity and Reduces Epileptiform Discharges in
hAPPJ20 Mice
(A–C) Average frequency (A) and amplitude (C) of sIPSCs and cumulative probability of sIPSC interevent intervals (IEI) (B) recorded from layer II/III and V pyramidal
cells. For statistical analyses, data from cells in layers II/III and V were combined (n = 21–27 cells per genotype). Nav1.1-BAC expression prevented sIPCS
frequency deficits in hAPPJ20 mice. *p < 0.05, ***p < 0.001 (ANOVA and Tukey test).
(D–J) EEG recordings from parietal cortex in NTG (n = 6), hAPPJ20 (n = 7), Nav1.1 (n = 9), and bigenic (n = 6) mice. The intensity of gamma activity (20–80 Hz) and
epileptiform discharges were measured in 1 min intervals for 60 min.
(D) Intensity of gamma activity.
(E and F) Cumulative probability of gamma intensity (E) and proportion of time spent at each gamma intensity (F) in hAPPJ20 and bigenic mice. Nav1.1-BAC
transgene expression increased the intensity of gamma activity in hAPPJ20 mice. p < 0.001 (two-sample Kolmogorov-Smirnov test).
(G) Spike frequency. Nav1.1-BAC transgene expression reduced spike frequency in hAPPJ20 mice.
(H) Spike frequency in hAPPJ20 and bigenic mice during periods of low, intermediate (inter), or high intensity of gamma activity.
(I) Exploratory activity during EEG recording.
(J) Significant increases in gamma activity during exploratory behavior (dark blue) were found in bigenic mice, but not in hAPPJ20 mice.
*p < 0.05, ***p < 0.001 (ANOVA and Tukey test) (D, G, H). *p < 0.05, **p < 0.01 (paired t test) (J). Numbers in bars are cells (A and C), minutes of recording (D, G–I), or
mice (J). Bars represent mean ± SEM.compared with hAPPJ20 mice (Figure 6E). hAPPJ20/Nav1.1
mice also spent more time at higher intensity values of gamma
activity than hAPPJ20 mice (Figure 6F). Thus, increasing
Nav1.1 levels in hAPPJ20 mice counteracts their gamma inten-
sity deficits.
Because network hypersynchrony decreases during high-
intensity gamma activity in unmanipulated hAPPJ20 mice (Fig-
ure 1), we tested whether Nav1.1-BAC-dependent increases ingamma activity are associated with reduced epileptic activity.
Increasing Nav1.1 levels in hAPPJ20 mice indeed reduced their
epileptiform discharges (Figure 6G). hAPPJ20/Nav1.1 mice had
fewer spikes than hAPPJ20 mice during low-intensity gamma
activity, but both groups had similar spike activity during
intermediate- and high-intensity gamma activity (Figure 6H),
suggesting that increased Nav1.1 levels primarily reduce epilep-
tiform discharges by modulating gamma activity. Mice of allCell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc. 715
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Figure 7. Increasing Nav1.1 Levels Ameliorates Spatial andContext-
Dependent Learning and Memory Deficits in hAPPJ20 Mice
NTG, hAPPJ20, Nav1.1, and hAPPJ20/Nav1.1 (bigenic) mice were tested to
assess spatial learning and memory in the Morris water maze and context-
dependent habituation and dishabituation to a novel environment in the
open field.
(A) Distance swum in the hidden (spatial) and visible (cued) platform com-
ponents of the Morris water maze test. In the spatial component, bigenic mice
performed better than hAPPJ20 mice. *p < 0.05, **p < 0.01, ***p < 0.001 (two-
way repeated-measures ANOVA and Bonferroni test).
(B) Platform crossings during the probe trial (platform removed). Only hAPPJ20
mice had memory retention deficits. *p < 0.05 versus nontarget locations
(paired two-tailed t test).
(C) Activity of mice in an open field was assessed on days 1–2, 7, and 23–24. In
these three sessions, bigenicmice habituated faster andmore completely than
hAPPJ20 mice. *p < 0.05, **p < 0.01, and ***p < 0.001 (two-way repeated-
measures ANOVA and Bonferroni test). Red asterisks indicate differences
between NTG and hAPPJ20 mice, and yellow asterisks indicate differences
between hAPPJ20 and bigenic mice.
(D) Only hAPPJ20 mice had memory retention deficits. ***p < 0.001 by ANOVA
and Tukey test.
(E) Survival curves. Nav1.1-BAC expression reduced premature mortality of
hAPPJ20 mice. ***p < 0.001 (Kaplan-Meier test). Values are mean ± SEM. See
Figure S5 for supporting data.genotypes showed similar levels of exploratory behavior during
the EEG recordings (Figure 6I).
As predicted from the results in Figure 1G, hAPPJ20 mice had
smaller increases of gamma activity during exploratory activity
than NTG mice (Figure 6J). This deficit was also ameliorated by
Nav1.1-BAC expression (Figure 6J). Thus, increasing Nav1.1
levels restores baseline gamma activity and increases of gamma
activity associated with exploratory behaviors.
Increasing Nav1.1 Levels Reduces Learning
and Memory Deficits and Premature Mortality
in hAPPJ20 Mice
To determine whether Nav1.1 alterations in hAPPJ20 mice con-
tribute to cognitive decline, we assessed spatial learning and
memory of mice in the Morris water maze. Compared with
NTG controls, hAPPJ20 mice were severely impaired in the
hidden platform component (days 1–5) of the test, but not in
the visible platform component (s1 and s2) (Figure 7A), indicating
specific spatial learning deficits. Increasing Nav1.1 levels by
Nav1.1-BAC expression reduced these spatial learning impair-
ments in hAPPJ20 mice and did not affect the performance of
mice without APP (Figure 7A). In the probe trial (platform
removed), only hAPPJ20 mice failed to cross the original plat-
form location more often than equivalent locations in nontarget
quadrants (Figure 7B). hAPPJ20/Nav1.1 mice performed at
control levels, indicating improved spatial learning and/or
memory retention.
Context-dependent habituation and dishabituation to a novel
environment were assessed in the open field. hAPPJ20/Nav1.1
mice habituated faster and more completely than hAPPJ20
mice (Figures 7C and S5; trials 1–4), suggesting improved
contextual learning. After four trials of testing, hAPPJ20/
Nav1.1 mice, but not hAPPJ20 mice, were completely habitu-
ated and indistinguishable in their activity from NTG and
Nav1.1 mice. Mice were retested in the same environment 5
and 15 days later to assess contextual memory. NTG and
Nav1.1 mice had persistently low levels of activity at 5 and
15 days (Figure 7C), indicating normal contextual memory.
Compared with these groups, hAPPJ20 mice showed
increased activity at 5 days and a marked increase in activity
at 15 days (Figures 7C and S5), indicating profound dishabitu-
ation (forgetting). The activity of hAPPJ20/Nav1.1 mice was
indistinguishable from that of controls at 5 days and interme-
diate between the activities of controls and hAPPJ20 mice at
15 days. Only hAPPJ20 mice had impaired memory retention
(Figure 7D). Additional training revealed again that hAPPJ20/
Nav1.1 mice habituated better than hAPPJ20 mice (Figure 7C;
trials 7–10). After ten trials, all genotypes were fully habituated
and indistinguishable from each other. Thus, deficits in contex-
tual learning and memory of hAPPJ20 mice depend on time
and experience. Overall, our data show that increasing Nav1.1
levels in hAPPJ20 mice enhances their capacity for learning
and memory.
hAPP mouse lines often die prematurely, likely from epileptic
activity (Hsiao et al., 1995; Ittner et al., 2010; Minkeviciene
et al., 2009; Palop et al., 2007; Roberson et al., 2007, 2011).
Increasing Nav1.1 levels in hAPPJ20 mice markedly improved
their survival (Figure 7E).716 Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc.DISCUSSION
This study identified alterations in the VGSC Nav1.1 subunit as a
mechanism of hAPP/Ab-induced aberrant network activity and
cognitive decline. hAPP mice and humans with AD had reduced
levels of Nav1.1. Restoring Nav1.1 levels in hAPP mice by
Nav1.1-BAC expression had profound and beneficial effects
on inhibitory synaptic currents, oscillatory rhythms, network
synchrony, cognitive functions, and premature mortality, high-
lighting the pathophysiological relevance of Nav1.1 depletion
in vivo. Because Nav1.1 is prominently expressed in inhibitory
PV cells in rodents and humans (Ogiwara et al., 2007; Wang
et al., 2011), our data suggest that dysfunction of PV cells and
inhibitory functions contribute to AD-related functional impair-
ments. Multiple lines of evidence support this conclusion: (1)
hAPP mice had decreased Nav1.1 levels in PV cells and altered
PV cell-dependent synaptic and network activity (gamma oscil-
lations), (2) network hypersynchronization intensified during
depressed gamma oscillations and diminished during increased
gamma activity, (3) inhibiting VGSCs and gamma oscillations
with VGSC blockers enhanced network hypersynchronization
and memory deficits in hAPP mice, and (4) increasing Nav1.1
expression enhanced inhibitory synaptic currents and gamma
activity and reduced network hypersynchronization andmemory
deficits in hAPP mice. These results pinpoint Nav1.1 reductions
as a key molecular mechanism, PV cells as a primary cellular
substrate, and PV cell-dependent alterations in gamma activity
and inhibitory deficits as functional mechanisms of network
and cognitive dysfunction in hAPP mice.
Nav1.1 Deficiency, Inhibitory Synaptic Dysfunction,
and Epilepsy
VGSCs control cellular excitability and produce sodium currents
involved in action potential generation (Meisler and Kearney,
2005). Loss-of-function mutations in Nav1.1 (SCN1A gene) or
microdeletions in one SCN1A allele cause epilepsy syndromes
in humans, ranging from benign febrile seizures to severe
myoclonic epilepsy of infancy (Catterall et al., 2010; Meisler and
Kearney, 2005; Suls et al., 2006). Inducing Nav1.1 haploinsuffi-
ciency in rodents causes severe epileptic activity and premature
mortality (Ogiwara et al., 2007; Yu et al., 2006). The degree of loss
of function in Nav1.1 mutations appears to determine the clinical
severity of the epilepsy syndromes (Catterall et al., 2010). The
epileptogenic mechanism underlying these conditions is closely
related to the restricted expression of theNav1.1 subunit in inhib-
itory interneurons, particularly PV cells (Lorincz and Nusser,
2008; Ogiwara et al., 2007; Wang et al., 2011), and their specific
impairments in action potential-driven activity (Ogiwara et al.,
2007; Yu et al., 2006). Consistent with these observations,
hAPP mice had reduced action potential-driven inhibitory syn-
aptic activity (sIPSCs) (Roberson et al., 2011). Increasing
Nav1.1 expression prevented sIPCS deficits in hAPP mice, indi-
cating that Nav1.1 depletion contributes to activity-dependent
inhibitory synaptic deficits. We could not obtain conclusive
evidence that action potential amplitude deficits in hAPP mice
are caused by reduced Nav1.1 levels. Additional alterations in
other ion channels, suchasNav1.6, andmoredepolarized resting
membrane potentials, which could result in larger steady-state
inactivation of VGSCs, may contribute to the amplitude deficits.
PV Cell-Dependent Gamma Activity and Network
Stability
Fast-spiking PV- and nonfast-spiking cholecystokinin (CCK)-
containing basket cells are the two major sources of periso-matic inhibition in the cerebral cortex and are specialized for
the primary control and fine-tuning of neuronal network oscilla-
tions, respectively (Freund and Katona, 2007). Reflecting this
functional dichotomy, PV cells are involved in disorders of
abnormal rhythmic synchrony, such as epilepsy, whereas
CCK cells are involved in mood disorders and anxiety (Freund
and Katona, 2007). Fast-spiking inhibitory PV basket cells
represent 40% of inhibitory interneurons and provide strong
somatic and perisomatic inhibition to excitatory pyramidal
cells. PV cells are electrically coupled by gap junctions and
therefore form a tightly connected interneuronal network. Their
combined fast-spiking inhibitory synaptic activity onto pyra-
midal cells generates a high-frequency oscillatory signature in
the gamma range (20–80 Hz). Increasing the firing of PV cells
by optogenetic stimulation increases the intensity of gamma
oscillatory activity (Cardin et al., 2009; Sohal et al., 2009).
Therefore, gamma activity likely reflects the inhibitory synaptic
activity of fast-spiking PV cells in vivo. Cell-autonomous im-
pairments of PV cell development reduce gamma activity and
cause network instability and epilepsy (Wang et al., 2010),
indicating that PV cells are critical in maintaining network
stability.
Consistent with PV cell dysfunction, behaving hAPP
mice had abnormal gamma activity. Notably, reduced gamma
activity correlated with increased epileptiform discharges, sug-
gesting a causal link between dysfunction of PV cells, reduced
gamma activity, and epileptiform activity in hAPP mice. Several
lines of evidence support this notion. Pharmacological inhibi-
tion of VGSCs further reduced gamma activity and proportion-
ally increased spike frequency. Increases in gamma activity
during exploratory behavior were associated with reduction
of spike frequency. Nav1.1-BAC transgene expression in-
creased gamma activity in Nav1.1 and hAPP/Nav1.1 mice
and reduced spike frequency in hAPP/Nav1.1 mice. Thus,
pharmacological, behavioral, and genetic manipulations of
gamma activity consistently modulated spike frequency in
the opposite direction, suggesting that these network alter-
ations are causally related to and mediated by Nav1.1 deple-
tions. Because increased spike activity could further reduce
gamma activity (Medvedev, 2002), this phenomenon could
create a vicious cycle in hAPP mice. However, specific
manipulations of gamma activity and epileptic spikes would
be needed to establish causal relations between these two
abnormalities.
GammaActivity, EpileptiformDischarges, andCognitive
Functions
Hippocampal and neocortical gamma activity are increased
during attention and learning, and such increases predict suc-
cessful memory formation in humans (Sederberg et al., 2007).
The importance of PV cell-mediated gamma activity for cogni-
tive function is strongly supported by the finding that enhancing
gamma activity by optogenetic stimulation of PV cells in-
creased performance of circuit processing by increasing
signal/noise ratio (Sohal et al., 2009). Gamma activity is re-
duced in AD patients (Herrmann and Demiralp, 2005). Similarly,
hAPP mice had reduced gamma activity at baseline and dimin-
ished inductions during exploratory activity. Increasing Nav1.1Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc. 717
levels prevented gamma activity deficits and ameliorated defi-
cits in contextual and spatial learning and memory, indicating
a causal role of Nav1.1 depletion in these deficits. Interestingly,
Nav1.1-BAC expression in hAPPJ20 mice had stronger
beneficial effects in memory or retrieval (e.g., water maze
probe trials or retrieval 2 week trial in the open field) than in
learning (e.g., water maze hidden training or habituation in
the open field), possibly reflecting improvements in neocortical
functions.
Altered gamma activity may relate to interneuronal dysfunc-
tion and cognitive alterations in other psychiatric and neurolog-
ical disorders, including epilepsy, autism, schizophrenia, and
attention deficit hyperactivity disorder (Cardin et al., 2009;
Fazzari et al., 2010; Herrmann and Demiralp, 2005). These and
our findings suggest that abnormal gamma activity directly
contributes to cognitive impairments and that PV cell dysfunc-
tion is an important underlying mechanism.
Seizure activity is increased in AD (Amatniek et al., 2006),
particularly in early-onset familial AD (FAD) (Palop and Mucke,
2009). Convulsive seizures occur in 7%–21% of sporadic AD
patients (Amatniek et al., 2006; Hauser et al., 1986; Mendez
and Lim, 2003), 30% of pedigrees carrying FAD PS1 muta-
tions (Larner and Doran, 2006), 31% of patients with PS2
mutations (Jayadev et al., 2010), 56% of patients with APP
duplications (Cabrejo et al., 2006), and 83% of pedigrees
with very early-onset AD (Snider et al., 2005). Behavioral or
EEG epileptic activity is also common in transgenic mouse
lines expressing FAD mutant hAPP, including Tg2576 (Hsiao
et al., 1995), hAPPJ20 (Palop et al., 2007), APP/PS1 (Minkevi-
ciene et al., 2009), EC-APP (Harris et al., 2010), hAPPJ9/FYN
(Roberson et al., 2011), and APP23 mice (Lalonde et al.,
2005). Increasing Nav1.1 levels in hAPPJ20 mice reduced
epileptic activity and improved cognitive functions, suggesting
that epileptic activity may contribute to cognitive impairments
in hAPP mice.
Potential Clinical and Therapeutic Implications
Cortical and hippocampal hyperactivity of neuronal networks is
an early event in AD pathogenesis and is associated with early
amyloid deposition in nondemented humans with or without
mild cognitive impairment (MCI) (Sperling et al., 2009). Impaired
inhibition has been suggested as a potential mechanism of
network hyperactivity (Busche et al., 2008; Palop et al., 2007;
Palop and Mucke, 2010; Sperling et al., 2009). Our findings
support this notion and suggest that behavioral interventions
or pharmacological manipulations that increase gamma activity
and/or reduce network hyperactivity have beneficial effects on
cognitive functions in the presence of pathologically elevated
Ab levels. They also suggest that pharmacological interventions
that reduce gamma activity (e.g., antiepileptic drugs affecting
sodium channel function) could impair cognitive function in
patients with AD or related disorders. In support of this observa-
tion, phenytoin increases AD risk in nondemented elderly people
(Carter et al., 2007) and causes acute cognitive decline in
Down’s syndrome patients with AD (Tsiouris et al., 2002). It
needs to be determined whether these mechanisms of cognitive
dysfunction are playing critical roles in all or only a subset of AD
patients. Mouse and human data suggest that early-onset FAD718 Cell 149, 708–721, April 27, 2012 ª2012 Elsevier Inc.patients with seizures might be particularly affected by these
alterations.
EXPERIMENTAL PROCEDURES
Transgenic Mice
We studied transgenic C57BL/6Jmice expressing hAPP with the Swedish and
Indiana FAD mutations and NTG littermate controls from line J20 (hAPPJ20
mice) (Mucke et al., 2000). For some experiments, hAPPJ20 mice were
crossed with BAC transgenic C57BL/6J mice expressing eGFP directed by
GAD67 regulatory sequences (Jackson Laboratory; strain: CB6-Tg(Gad1-
EGFP)G42Zjh/J, line G42) (Chattopadhyaya et al., 2004) or Nav1.1-BAC
transgenic FVB/N mice from line one overexpressing wild-type murine
Nav1.1 (Tang et al., 2009). For all crosses, we analyzed littermates from the
F1 offspring. Unless indicated otherwise, measurements were performed in
4- to 7-month-old mice.
Human Tissues
Inferior parietal cortex was dissected from frozen brains of 22 AD cases
(age 78.4 ± 10.8 years, mean ± SD) and 7 nondemented controls (age 83.5 ±
15.3 years) from the Alzheimer’s Disease Research Center, University of
California, San Diego. See Extended Experimental Procedures.
Immunohistochemistry
Tissue preparation and immunohistochemistry were performed as described
(Palop et al., 2003, 2007). Primary antibodies used included rabbit anti-
parvalbumin (Swant), rabbit anti-Nav1.1 (Alomone), rabbit anti-Nav1.6
(Alomone), and mouse anti-GAD67 (Chemicon). Primary antibodies were
detected with biotinylated goat anti-rabbit (Vector Laboratories) or with
fluorescein-labeled donkey anti-rabbit (Jackson ImmunoResearch), Alexa
594 donkey anti-mouse (Invitrogen), or Alexa 488 donkey anti-rabbit (Invitro-
gen). See Extended Experimental Procedures.
In Situ Hybridization
Tissue preparation and in situ hybridization were performed as described
(Palop et al., 2007). Antisense and sense RNA digoxigenin-labeled probes
were generated from EST clones (Open Byosystems) (NCBI#: BE944238 for
Nav1.1 and AI839069 for Nav1.6). Digoxigenin-labeled probes were detected
with the HNPP fluorescent detection set (Roche), followed by standard fluores-
cence immunohistochemistry with polyclonal anti-PV (Swant) or anti-GFP
(Molecular Probes) antibodies. Nav1.1- and PV-positive neurons were quanti-
fied in two sections, 100 mm apart. In all, 551 neurons positive for PV and/or
Nav1.1 were identified and analyzed. The proportion of PV-positive cells
expressing Nav1.1mRNA (PV+/Nav1.1+) and the relative Nav1.1mRNA signal
intensity in PV cells were calculated for each genotype.
Western Blot Analysis
Microdissections and western blot analysis were performed as described
(Palop et al., 2005). Primary antibodies included rabbit anti-Nav1.1 (Alomone),
rabbit anti-Nav1.2 (Alomone), rabbit anti-Nav1.3 (Alomone), rabbit anti-Nav1.6
(Alomone), rabbit anti-GAD67 (Millipore), rabbit anti-calretinin (Swant), rabbit
anti-parvalbumin (Swant), rabbit anti-calbindin (Swant), mouse anti-reelin
(Millipore), and mouse anti-a-tubulin (Sigma). Primary antibodies were
detected with horseradish peroxidase-conjugated secondary anti-mouse
IgG antibody (Calbiochem) or HRP-conjugated goat anti-rabbit IgG (Calbio-
chem). Bands were visualized by ECL and quantitated densitometrically with
ImageQuant software (Molecular Dynamics). See Extended Experimental
Procedures.
Slice Electrophysiology
sIPSCs were recorded at the reversal potential of ionotropic glutamate
receptors (0 mV), sEPSCs were recorded at the reversal potential of GABAA
receptors (65 mV), and mIPSCs and mEPSCs were recorded in the pre-
sence of 0.5 mM tetrodotoxin and 50 mM CdCl2. Signals were acquired with
Axoclamp 2A, MultiClamp 700B, or Axopatch 200A amplifiers (Molecular
Devices). Voltage- and current-clamp recordings were analyzed in Igor Pro
(Wavemetrics) with custom-written procedures. For detection of synaptic
events in voltage-clamp recordings, events were detected as deflections
exceeding 5–7 pA above baseline mean. From each recording, 500–1000
consecutive events were sampled.
To analyze the intrinsic properties of neurons recorded in current-clamp
mode, the input resistance was estimated at the resting membrane potential
in response to 500 ms hyperpolarizing current steps of 20–40 pA. The
membrane time constant and capacitance were estimated by fitting single
exponentials to initial phases of these voltage responses. For analysis of action
potential properties, neurons were recorded at resting or at 70 mV
membrane potentials and depolarized with 800 ms current steps in 20 pA
increments. See Extended Experimental Procedures.
EEG Recordings
EEG activity in freely moving mice was recorded with the Harmonie 5.0b
software (Stellate). Sharp-wave discharges were automatically detected
by the Gotman spike detectors (Harmonie, Stellate). Spectral analysis
was analyzed using a custom-written procedure running under Igor Pro
(Wavemetrics). The gamma frequency band (gamma activity) represents the
average of the spectral values in the 20–80 Hz range (Barth and Mody,
2011). Low, intermediate, and high intensity of gamma activities were defined
as minutes with values <30%., 30%–60%, and >60% of the total amplitude of
the gamma activity. See Extended Experimental Procedures.
Drug Treatments
For acute treatments, riluzole was dissolved at 2 mg/ml in 50% polyethylene
glycol 400 in distilled water and intraperitoneally injected at 20 mg/kg, and
phenytoin was dissolved at 10 mg/ml in phosphate-buffered saline and in-
traperitoneally injected at 100 mg/kg. For chronic treatment, phenytoin was
dissolved daily in the drinking water at 0.15–0.75 mg/ml to reach final doses
of 25, 50, 70, and 85 mg/kg/day.
Morris Water Maze
Mice were trained to locate the hidden platform more than 5 consecutive days
(two sessions of two trials per day, 4 hr apart). Four hours after the last training
session, the platform was removed, and a 60 s probe trial was performed.
Two days later, mice were trained to locate the visible platform over two
sessions of two trials each. Performance was monitored with an EthoVision
video tracking system (Noldus Information Technology). See Extended Exper-
imental Procedures.
Open Field Behavior
Exploratory locomotor activity wasmeasured in an open field (automated Flex-
Field/Open Field Photobeam Activity System, San Diego Instruments). Mice
were placed in one of four identical clear plastic chambers (40 3 40 3
30 cm) for 5 min (Figure 7) or 15 min (Figure 4). Total movements in the open
field were reported. See Extended Experimental Procedures.
Statistical Analysis
Statistical analyses were performedwith SPSS 10.0, STATA 11.2, or Prism 5.0.
Experimenters were blinded with respect to genotype and treatment of mice
and to diagnosis of human cases. See Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
five figures, and one table and can be found with this article online at
doi:10.1016/j.cell.2012.02.046.
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